admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

atai Life Sciences Makes $50m Investment in Beckley Psytech

Exploring Conscious Creativity: Developing Authenticity in the Digital Age with Daníel...

Gender Challenges in Psychedelic Retreats and Clinical Settings

Developing Cultural Awareness in Business & Practice

PT474 – The Origin of Psychedelics Today and the Growth of...

PT473 – Microdosing for Healing: The Importance of Journaling and Group...

Kentucky’s $42m Ibogaine Funding Appears Dead in the Water

Ayahuasca Chronicles: Exploring Amazonian Traditions and Nature Connectedness with Paloma David...

PT472 – Psychedelics and Comedy: Finding the Humor in Personal Growth

PT471 – The Evolution of LSD Psychotherapy, the Power of Breathwork,...

1...343536...218 Page 35 of 218

EDITOR PICKS

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin